Cara Therapeutics
CARA
#10952
Rank
โ‚น0.75 B
Marketcap
โ‚น492.95
Share price
-2.56%
Change (1 day)
23.51%
Change (1 year)

Earnings for Cara Therapeutics (CARA)

Earnings in 2024 (TTM): -โ‚น5.26 Billion

According to Cara Therapeutics 's latest financial reports the company's current earnings are โ‚น7.13 Million. , an increase over its 2023 earnings that were of -โ‚น10.68 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cara Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚น5.82 Billion-45.49%
2023 -โ‚น10.68 Billion31.6%
2022 -โ‚น8.12 Billion-1.74%
2021 -โ‚น8.26 Billion-1754.28%
2020 โ‚น0.49 B-104.82%
2019 -โ‚น10.35 Billion44.32%
2018 -โ‚น7.18 Billion30.09%
2017 -โ‚น5.52 Billion1.86%
2016 -โ‚น5.42 Billion131.86%
2015 -โ‚น2.34 Billion39.38%
2014 -โ‚น1.68 Billion9120.41%
2013 -โ‚น18.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น1.734 T-29,914.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น645.65 B-11,196.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-โ‚น2.88 Billion-50.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
โ‚น0.34 B-105.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-โ‚น7.36 Billion 26.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-โ‚น25.19 Billion 332.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-โ‚น0.96 Billion-83.62%๐Ÿ‡บ๐Ÿ‡ธ USA